Joshua K. Ochieng

The University of Texas MD Anderson Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial”.

Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00095-0

N/A

0.807DataRank · unranked

27 citations

Vania Balderrama-Brondani, Camilo Jiménez, Gina Tamsen, Leonardo P. Marcal, Jeena Varghese +7 more

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

Nature Communications(2021)10.1038/s41467-021-22875-w

N/A

0.639DataRank · unranked

70 citations

B. Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica Konen +9 more

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Cancer Research(2021)10.1158/0008-5472.can-20-1895

N/A

0.520DataRank · unranked

31 citations

B. Leticia Rodriguez, Aparna Padhye, Joshua K. Ochieng, Laura Gibson, Lixia Diao +9 more

Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS mutant lung cancer

Research Square(2021)10.21203/rs.3.rs-355354/v1

N/A

0.208DataRank · unranked

3 citations

Jessica Konen, B. Leticia Rodriguez, Jared J. Fradette, Joshua K. Ochieng, Lixia Diao +11 more

Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer

JCI Insight(2021)10.1172/jci.insight.148392

N/A

0DataRank · unranked

18 citations

Jessica Konen, B. Leticia Rodriguez, Jared J. Fradette, Joshua K. Ochieng, Lixia Diao +11 more

Next-Generation Immunotherapies to Improve Anticancer Immunity

Frontiers in Pharmacology(2021)10.3389/fphar.2020.566401

N/A

0DataRank · unranked

19 citations

Katarzyna Tomczak, June Li, Joshua K. Ochieng, Young‐Hee Lee, Cara Haymaker +1 more

Data from Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

(2023)10.1158/0008-5472.c.6512518.v1

N/A

0DataRank · unranked

0 citations

B. Leticia Rodriguez, Aparna Padhye, Joshua K. Ochieng, Laura F. Gibson, Lixia Diao +9 more